is compound tirzepatide fda approved Lilly seeks to intervene in compounded lawsuit FDA confirms tirzepatide shortage is

Shoback DM et al

By influencing nicotinamide methyltransferase (NNMT) activity, these synthetic peptides may help in regulating how the body processes and stores fat

Invest Ophthalmol Vis Sci 2004

Eli Lilly says that Zepbound is a dual receptor agonist that targets both GIP and GLP-1 receptors, unlike other incretins approved for obesity management, which target only GLP-1 receptors. And Novo Nordisk says that Wegovy has the broadest GLP-1 label, including indications for reducing risk of major adverse cardiovascular events in some patients and for treatment of a certain liver condition in some adults

Sermorelin is a gentler option that supports growth hormone production more broadly